Middle Eastern Opportunities: 3 Penny Stocks With Market Caps Under US$700M
Top 10 Penny Stocks In The Middle East
Name
Share Price
Market Cap
Financial Health Rating
Big Tech 50 R&D-Limited Partnership (TASE:BIGT)
₪1.391
₪14.76M
★★★★★★
Thob Al Aseel (SASE:4012)
SAR3.89
SAR1.56B
★★★★★★
Alarum Technologies (TASE:ALAR)
₪4.173
₪294.79M
★★★★★★
Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi (IBSE:MEGAP)
TRY4.75
TRY1.31B
★★★★★☆
E7 Group PJSC (ADX:E7)
AED1.55
AED3.1B
★★★★★★
Al Wathba National Insurance Company PJSC (ADX:AWNIC)
AED3.27
AED676.89M
★★★★★☆
Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR)
AED3.30
AED381.15M
★★★★★★
Dubai Investments PJSC (DFM:DIC)
AED2.96
AED12.63B
★★★★☆☆
Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)
AED0.787
AED480.52M
★★★★★★
Tgi Infrastructures (TASE:TGI)
₪2.594
₪192.84M
★★★★★★
Click here to see the full list of 77 stocks from our Middle Eastern Penny Stocks screener.
Let's review some notable picks from our screened stocks.
United Arab Bank P.J.S.C
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: United Arab Bank P.J.S.C. offers commercial banking products and services to institutional and corporate clients in the United Arab Emirates, with a market capitalization of AED 2.48 billion.
Operations: The company's revenue is derived from three main segments: Retail Banking (AED 74.79 million), Wholesale Banking (AED 468.96 million), and Treasury and Capital Markets (AED 209.62 million).
Market Cap: AED2.48B
United Arab Bank P.J.S.C. presents a compelling case for investors interested in penny stocks, with a market capitalization of AED 2.48 billion and diverse revenue streams across retail, wholesale banking, and treasury markets. The bank's Price-To-Earnings ratio (6.7x) is attractively below the AE market average, suggesting potential value. Recent earnings reports indicate strong growth, with net income rising to AED 106.18 million in Q2 2025 from AED 70.27 million the previous year. Despite high bad loans (2.2%), UAB maintains an appropriate Loans to Deposits ratio (75%) and stable weekly volatility (6%).
Click here to discover the nuances of United Arab Bank P.J.S.C with our detailed analytical financial health report.
Assess United Arab Bank P.J.S.C's previous results with our detailed historical performance reports.
Union Insurance Company P.J.S.C
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Union Insurance Company P.J.S.C. provides insurance products across the United Arab Emirates, Gulf Cooperation Council, and international markets with a market cap of AED229.99 million.
Operations: The company's revenue is derived from two main segments: Life Insurance, which generated AED16.83 million, and General Insurance, contributing AED246.91 million.
Market Cap: AED230M
Union Insurance Company P.J.S.C. stands out in the penny stock arena with a market cap of AED229.99 million and a focus on life and general insurance, generating AED263.74 million in revenue. The company has recently become profitable, reporting Q1 2025 net income of AED13.05 million, up from AED11.78 million the previous year, despite low Return on Equity at 15.4%. With no debt and a Price-To-Earnings ratio of 5.8x below the AE market average, it offers potential value but is impacted by large one-off gains (AED14.2M) affecting earnings quality and faces challenges covering long-term liabilities with short-term assets (AED737.9M).
Click here and access our complete financial health analysis report to understand the dynamics of Union Insurance Company P.J.S.C.
Understand Union Insurance Company P.J.S.C's track record by examining our performance history report.
PlantArc Bio
Simply Wall St Financial Health Rating: ★★★★★★
Overview: PlantArc Bio Ltd. is an Ag-Bio company focused on crop protection and yield enhancement, with a market cap of ₪6.63 million.
Operations: The company generates revenue from its Agricultural Biotech segment, amounting to ₪4.40 million.
Market Cap: ₪6.63M
PlantArc Bio Ltd., with a market cap of ₪6.63 million, operates in the Ag-Bio sector focusing on crop protection and yield enhancement. The company is pre-revenue, generating only ₪4.40 million from its Agricultural Biotech segment, which is not considered significant revenue. Despite being unprofitable, PlantArc Bio has no debt and boasts a cash runway exceeding three years based on current free cash flow trends. Its management team and board are experienced with average tenures of 4.8 and 4.3 years respectively, although the stock price remains highly volatile compared to most IL stocks over recent months.
Take a closer look at PlantArc Bio's potential here in our financial health report.
Examine PlantArc Bio's past performance report to understand how it has performed in prior years.
Seize The Opportunity
Gain an insight into the universe of 77 Middle Eastern Penny Stocks by clicking here.
Interested In Other Possibilities? This technology could replace computers: discover the 26 stocks are working to make quantum computing a reality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ADX:UAB ADX:UNION and TASE:PLNT.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
Middle Eastern Penny Stocks: Gulf Pharmaceutical Industries P.S.C And Two More To Watch
The Middle Eastern stock markets have been experiencing mixed performances, with some indices buoyed by hopes of a U.S. Federal Reserve rate cut while others are weighed down by weaker corporate earnings. In this context, penny stocks—though an older term—remain relevant as they often represent smaller or less-established companies that can offer significant value when backed by strong financials. This article will highlight three such penny stocks in the Middle East, focusing on their potential for long-term growth and stability amidst current market conditions. Top 10 Penny Stocks In The Middle East Name Share Price Market Cap Financial Health Rating Big Tech 50 R&D-Limited Partnership (TASE:BIGT) ₪1.414 ₪15M ★★★★★★ Thob Al Aseel (SASE:4012) SAR3.71 SAR1.48B ★★★★★★ Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi (IBSE:MEGAP) TRY4.75 TRY1.31B ★★★★★☆ E7 Group PJSC (ADX:E7) AED1.47 AED3B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY2.97 TRY3.2B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.45 AED392.7M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.89 AED12.25B ★★★★☆☆ Al Dhafra Insurance Company P.S.C (ADX:DHAFRA) AED4.86 AED486M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.828 AED488.43M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.937 ₪218.34M ★★★★★★ Click here to see the full list of 76 stocks from our Middle Eastern Penny Stocks screener. Here's a peek at a few of the choices from the screener. Gulf Pharmaceutical Industries P.S.C Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Gulf Pharmaceutical Industries P.S.C., also known as Julphar, manufactures and sells a range of pharmaceutical, cosmetic, and medical products in the UAE, GCC countries, and internationally with a market cap of AED1.68 billion. Operations: The company's revenue segments include AED732.9 million from Planet and AED864.9 million from Manufacturing. Market Cap: AED1.68B Gulf Pharmaceutical Industries P.S.C., known as Julphar, has shown a positive shift in its financial performance, reporting a net income of AED 157.9 million for the first half of 2025 compared to a net loss the previous year. The company's debt is well-managed with operating cash flow covering 31.1% and a reduced debt-to-equity ratio from 117% to 55.9% over five years, indicating improved financial health. Despite low return on equity at 2.4%, Julphar's profitability and stable weekly volatility are promising traits for investors interested in Middle Eastern penny stocks with potential growth prospects amidst operational challenges. Get an in-depth perspective on Gulf Pharmaceutical Industries P.S.C's performance by reading our balance sheet health report here. Examine Gulf Pharmaceutical Industries P.S.C's earnings growth report to understand how analysts expect it to perform. Sinpas Gayrimenkul Yatirim Ortakligi Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Sinpas Gayrimenkul Yatirim Ortakligi, originally established as Sinpas Insaat Anonim Sirketi in 2006 and transformed into a Real Estate Investment Trust (REIT) in 2007, operates in the real estate sector with a market capitalization of TRY17.76 billion. Operations: The company generates revenue primarily from its Residential Real Estate Developments segment, amounting to TRY12.64 billion. Market Cap: TRY17.76B Sinpas Gayrimenkul Yatirim Ortakligi has demonstrated robust financial health, with short-term assets of TRY14.8 billion comfortably covering both its short and long-term liabilities. The company has experienced significant earnings growth, notably an 86.4% increase over the past year, surpassing industry averages. However, a substantial one-off gain of TRY5.3 billion skews recent earnings quality. While its net debt to equity ratio is satisfactorily low at 14.2%, interest coverage remains weak at 2.1 times EBIT, suggesting potential pressure in meeting debt obligations despite stable weekly volatility and reduced debt levels over five years. Unlock comprehensive insights into our analysis of Sinpas Gayrimenkul Yatirim Ortakligi stock in this financial health report. Review our historical performance report to gain insights into Sinpas Gayrimenkul Yatirim Ortakligi's track record. Oil Refineries Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Oil Refineries Ltd. operates in the production and sale of fuel products, intermediate materials, and aromatic products both in Israel and internationally, with a market cap of ₪2.64 billion. Operations: Currently, there are no reported revenue segments for Oil Refineries Ltd. Market Cap: ₪2.64B Oil Refineries Ltd. faces challenges with a net loss of US$37 million in Q2 2025, contrasting with a profit last year. Despite this, its financial structure shows resilience; short-term assets of US$2 billion surpass both short and long-term liabilities. While the dividend yield is high at 10.22%, it isn't supported by earnings, raising sustainability concerns. Debt management has improved over five years, reducing from 127.7% to 75.3%. However, interest payments remain uncovered by EBIT and the company remains unprofitable despite shrinking losses annually by 25.8%. Management's experience offers some stability amid these hurdles. Dive into the specifics of Oil Refineries here with our thorough balance sheet health report. Explore historical data to track Oil Refineries' performance over time in our past results report. Turning Ideas Into Actions Click here to access our complete index of 76 Middle Eastern Penny Stocks. Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:JULPHAR IBSE:SNGYO and TASE:ORL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Business Insider
3 hours ago
- Business Insider
Quantum Leap: Rivals eye full-scale quantum computer finish line before 2030
Welcome to the latest edition of 'Quantum Leap' where The Fly decodes news and activity in the quantum computing space. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. VISIONS OF 2030: After a series of recent technical breakthroughs, the creation of full-scale quantum computers may be possible by the end of the decade, Richard Waters of The Financial Times reported. Back in June, IBM (IBM) became the latest to claim its path was clear to a full-scale machine, believing it could build the machine by the end of the decade. This has intensified its race with Google (GOOGL), which announced last year it cleared on of its largest remaining hurdles on creating one and said it was on course to finish by the end of the decade. QUBITS JAPAN: D-Wave Quantum (QBTS) announced that it is hosting its first-ever Qubits Japan 2025 quantum computing user conference in Tokyo on September 17. Themed 'Quantum Realized,' Qubits Japan 2025 will feature presentations from D-Wave executives, customers, and thought leaders. The event comes as D-Wave's bookings in the APAC region are up 83% over the past 12 months. CFO TRANSITION: FormFactor (FORM) announced that Aric McKinnis, currently its VP and corporate controller, has been appointed to serve as the company's new senior VP and CFO. He succeeds Shai Shahar, who resigned from these positions effective August 8. Shahar will remain a FormFactor employee as senior VP, executive advisor through December 31. R&D HUB: Sealsq (LAES) unveiled the progress of its Lab, a next-generation research and development hub focused on the convergence of quantum computing, and cybersecurity now expanding into artificial intelligence. With a total of $30M investment capacity, the Lab has already invested in quantum technology startups like ColibriTD and made the acquisition of semiconductor design service specialist IC'ALPS to develop solutions for semiconductor manufacturing and post-quantum security. SCALEUP X: Arqit Quantum (ARQQ) announced that it has joined the 2025 cohort of Tomorrow Street's Scaleup X program. The collaboration provides Arqit with access to Tomorrow Street's global network and ecosystem, creating opportunities to scale its technology across Vodafone's (VOD) ecosystem. Andy Leaver, CEO of Arqit, commented: 'We are thrilled to join Tomorrow Street's Scaleup X Programme. In the International Year of Quantum Science and Technology, there's global recognition of the urgent need to adopt quantum-safe encryption solutions. The ability to engage with Tomorrow Street's ecosystem provides a major opportunity to accelerate commercial deployments and deliver next-generation cyber security to customers across telecoms, critical infrastructure and enterprise sectors.' NEW CHAIR: IonQ 's (IONQ) board of directors has appointed CEO Niccolo de Masi to the additional position of chairman of the board, effective immediately. As a result, Peter Chapman has stepped down as executive chairman and as a member of the board. EARNINGS RECAP: Shares of Rigetti Computing (RGTI) dipped 3% after the company's Q2 results fell shy of expectations. Net loss in the quarter included $22.8M of non-cash losses for the fair value change in the derivative warrant and earn-out liabilities. 'It's our view that superconducting qubits are the leading modality for quantum computers due to their ability to scale, and their ability to achieve gate speeds more than 1,000 times faster than other modalities like ion traps and pure atoms. Rigetti's superconducting qubits leverage technologies, like chiplets, that have been maturing in the semiconductor industry for decades, enabling Rigetti to use well-established methods to scale to higher performance and qubit counts,' CEO Subodh Kulkarni commented. D-Wave reported mixed Q2 results, beating revenue expectations, but missing the EPS mark compared with analyst consensus. Bookings for the second quarter were $1.3M. 'Our second quarter results show consistently strong performance across a multitude of technical and business metrics,' said Alan Baratz, CEO of D-Wave. 'During the quarter, we brought to market our sixth-generation quantum computer, signed a memorandum of understanding related to the acquisition of an on-premises system in South Korea, completed physical assembly of the previously announced system at Davidson Technologies, introduced a collection of developer tools to advance quantum AI and machine learning innovation, and ended the quarter with a record $819 million in cash. We're confident in our ability to continue delivering long-term value for our customers, partners and shareholders.' Piper Sandler raised the firm's price target on D-Wave Quantum to $22 from $13 and maintained an Overweight rating on the shares. The firm notes the company reported June earnings in which revenue was slightly above expectations into the print. The company is currently benefiting from the availability of its Advantage2 system and general quantum computing traction which came online in the June quarter, the firm told investors in a research note. Similarly, IonQ also experienced a mixed second quarter. Cash, cash equivalents, and investments were $656.8M as of June 30 and $1.6B pro-forma as of July 9. The balance increased due to the $1B equity financing. CEO Niccolo de Masi said, 'I am pleased to report that we beat the top end of guidance for Q2 revenue by 15%, and strengthened our balance sheet via the largest equity investment from a single institution in the quantum industry. We also made very tangible progress towards delivering our #AQ64 application performance benchmark, with strong indications that it will be achieved in the near term.' ADDITIONAL ANALYST COMMENTARY: DA Davidson downgraded IonQ to Neutral from Buy with an unchanged price target of $35. IonQ continues to invest heavily for what the firm believes will be 'the next big technological paradigm of this generation,' but risks associated with the business have notably increased given limited clarity relating to the roadmap and near-to-medium term profitability, said the analyst, who is moving to the sidelines based on 'various moving pieces and limited visibility.'
Yahoo
5 hours ago
- Yahoo
If You'd Invested $1,000 in D-Wave Quantum Stock 1 Year Ago, Here's How Much You'd Have Today
Key Points D-Wave Quantum stock has been extremely volatile since going public through a SPAC merger roughly three years ago. While the stock has underperformed the market over the last three years, it's actually increased more than 10x over the last one-year stretch. D-Wave stock is a risky play, but it could continue rocketing higher if the company delivers tech breakthroughs. 10 stocks we like better than D-Wave Quantum › Quantum computing has emerged as one of the most exciting, potentially explosive plays for growth investors, and D-Wave Quantum (NYSE: QBTS) stock has seen huge valuation gains in conjunction with the trend. As of this writing on Aug. 10, the company's share price has roughly doubled across 2025's trading. While the stock has posted big returns in 2025, investors who bought the stock exactly one year ago would have seen gains that absolutely dwarf that performance. Read on to see the incredible sum that $1,000 invested in D-Wave would now be worth and a look at key performance drivers for the company going forward. D-Wave stock has delivered more than 10x returns over the last year D-Wave Quantum went public through a merger with a special purpose acquisition company (SPAC) in August 2022. The stock is up just 40% over the last three years, as I write this, significantly underperforming the S&P 500's total return level of roughly 59% across the stretch. On the other hand, the stock's performance over the last year has blown returns for the broader market out of the water. D-Wave Quantum stock has skyrocketed roughly 1,910% over the last year -- absolutely crushing the S&P 500's total return of approximately 21% across the stretch. With those gains, a $1,000 investment in D-Wave one year ago would now be worth more than $20,000. With the second-quarter report that it published earlier this month, the company reported a non-GAAP (adjusted) loss of $0.08 per share on sales of approximately $3.1 million. For comparison, the average analyst estimate had called for the business to post an adjusted loss of $0.05 per share on sales of roughly $2.54 million, so it "beat" the top-line estimate but "missed" the bottom-line one. D-Wave is still in a very early growth stage. The speculative nature of the quantum computing industry at large and D-Wave's individual positioning in the space make the stock a very risky play, but it's possible that future tech breakthroughs will help power more big gains for the stock. Should you buy stock in D-Wave Quantum right now? Before you buy stock in D-Wave Quantum, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and D-Wave Quantum wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025 Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. If You'd Invested $1,000 in D-Wave Quantum Stock 1 Year Ago, Here's How Much You'd Have Today was originally published by The Motley Fool Sign in to access your portfolio
